SCHEMBL7616233

SCHEMBL7616233

CC(C)(C)[Si](C)(C)OCc1ccc(OCc2cc(CCCO)cs2)cc1CO[Si](C)(C)C(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.34
EPHX2 P34913 1/20 0.34
PPARA Q07869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7649567 0.88
SCHEMBL7606423 0.84
SCHEMBL6563887 0.81 MGMT (0.35)
SCHEMBL6563146 0.77 BACE1 (0.33)
SCHEMBL6563085 0.77 CA2 (0.30)
SCHEMBL6563010 0.77 MAPT (0.33)
SCHEMBL6562766 0.76
SCHEMBL6889628 0.76
SCHEMBL6889630 0.76
SCHEMBL6564967 0.73 VDR (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235824-A1 VITAMIN D ANALOGUES Galderma Research & Development, S.N.C. (FR) 2002-09-04 EP disclosed
WO-2001038320-A1 VITAMIN D ANALOGUES GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2001-05-31 WO disclosed